WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 9901 Infant (under 12 months) mortality rate: 492
GDP / capita (US$): 2'5121 Child (under 5 years) mortality rate: 582

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 8'208  8'009  7'815  7'627  7'447  6'186  5'297  3'918 
Births 271  265  258  249  240  189  212  155 
Surviving infants 256  250  244  235  226  176  192  137 
Pop. less than 5 years 1'195  1'150  1'096  1'029  981  888  955  626 
Pop. less than 15 years 2'946  2'874  2'806  2'739  2'698  2'653  2'311  1'683 
Female 15-49 years 2'154  2'113  2'072  2'032  1'984  1'492  1'175  872 

Number of reported case

(Click for retrospective incidence data for Tajikistan)
Diphtheria 11  11 
Japanese encephalitis
Measles 16  192  6'897 
Mumps 1'530  1'518  1'441  1'558  1'200  428 
Pertussis 56  12  13  935 
Polio* 457 
Rubella 179  111 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Tajikistan)
Vaccine year result method % card seen                                                
BCG 2011  98  DHS   91  98  97  97  98  83  99 
DTP1 2011  98  DHS   91  98  96  98  95  96  98 
DTP3 2011  93  DHS   91  96  94  96  93  93  96 
HepB_BD          98  98  98  96  97 
HepB3 2011  93  DHS   91  96  94  96  93  93 
Hib3 2011  93  DHS   91  96  94  96  93  93 
JapEnc         
MCV 2011  95  DHS   91  92  95  98  94  89  98 
MCV2          92  97  96  81  93  31 
PCV1         
PCV3         
Pol3 2011  92  DHS   91  97  96  97  95  93  98 
Rota1         
Rota_last         
Rubella1          92  94  89 
TT2plus         
PAB         
VAD1          97  100  98  97 
YFV          98 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Tajikistan)
BCG 98  97  97  98  82  98 
DTP1 98  96  98  95  96  88 
DTP3 96  94  96  93  93  83 
HepB3 96  94  96  93  93 
HepB_BD 98  98  98  96  97 
Hib3 96  94  96  93  93 
MCV 92  94  98  94  89  88 
MCV2 92  97  96  95  93  59 
PnC3
Pol3 97  96  97  95  93  86 
Rota_last

Number of districts in the country 66  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; Yes
DT 6 years; Yes
DTwP 16-23 months; Yes
DTwPHibHep 2, 3, 4 months; Yes
HepB birth; Yes
MR 12 months, 6 years; Yes
OPV birth; 2, 3, 4, 12 months; Yes
Td 16, 26, 36, 46, 56 years; Yes
VitaminA 6-11, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2010-2015  2011-2015  2011-2015  2007-2010  2008-2010  2008-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 66  66  66  65  65  66  65 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 66  66  66  65  65  66  65 
Nº districts with DTP3 coverage >=80% number 66  66  66  65  65  60  65 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  91  100 
Nº districts with measles (MCV1) coverage >=95% number 60  59  59  46  63   
% of districts with MCV1 coverage >=95% From 0 to 100% 91  89  89  71  97   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 25  16  18    17    10 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.